Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List"

NCT05846672 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-12-12

No results posted yet for this study

Summary

The ultimate goal of treating children with lower extremity differences is to improve quality of life, optimize function, and maximize participation by addressing the physical, social, and psychological effects of lower extremity differences. In the pediatric field, research has focused on the Body Functions and Structures area of the ICF framework, such as radiographic measurements of limb alignment and length, postoperative complications, and recovery time. Priority targets for children/parents are better captured in the Activity and Participation areas of the ICF framework.

Developed in Canada, the Gait Outcomes Assessment List (GOAL)was created to evaluate outcomes for gait-related interventions for children with cerebral palsy based on a wide range of children's and parents' goals. It was also developed for other childhood conditions associated with lower extremity disorders. The present study aimed to determine the Turkish cultural adaptation, validity, and reliability of the "Gait Outcomes Assessment List for Children With Lower-Limb Difference Parent Version/ Child Version" in Pediatric Rheumatologic Diseases.

Conditions

  • Rheumatologic Disease
  • Pediatric ALL
  • Children, Only
  • Lower Extremity Problem

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Nilay Arman, Assoc. Prof. · Istanbul University-Cerrahpaşa, Faculty of Health Science

  • Asena Yekdaneh, Pt. MSc. · Fenerbahce University

  • Asya Albayrak, Pt. MSc. · Istanbul Kent University

  • Nuray Aktay Ayaz, Prof. Dr. · Istanbul University Medical Faculty

  • Ayşenur Namlı, Pt. MSc. · Aydın University

  • Fatma Gül Demirkan, MD · Istanbul University Medical Faculty

  • Özlem Akgün, MD · Istanbul University Medical Faculty

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-30
Primary Completion
2023-10-30
Completion
2023-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05846672 on ClinicalTrials.gov